Back
Intellia Therapeutics Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
29
NTLA
Intellia Therapeutics
Last Price:
$12.07
Seasonality Move:
-9.64%
Sell
32
ASND
Ascendis Pharma AS
Last Price:
$170.13
Seasonality Move:
11.4%
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
-
The current Intellia Therapeutics [NTLA] share price is $12.06. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $169.90. The Score for ASND is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $12.06Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $169.90The current trend is moderately bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.3 | Buy |
Relative Strength Index (14 RSI): | 65.89 | Buy |
Chaikin Money Flow: | -1627212 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.12 - 11.58) | Buy |
Bollinger Bands (100): | (7.5 - 10.36) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.14 | Buy |
Relative Strength Index (14 RSI): | 45.73 | Sell |
Chaikin Money Flow: | -572719 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (171.3 - 176.56) | Sell |
Bollinger Bands (100): | (152.54 - 172.86) | Buy |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.89 | Buy |
20-day SMA: | 10.7 | Buy |
50-day SMA: | 9.34 | Buy |
200-day SMA: | 11.51 | Buy |
8-day EMA: | 10.63 | Buy |
20-day EMA: | 7.02 | Buy |
50-day EMA: | 3.57 | Buy |
200-day EMA: | 1.02 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 174.91 | Sell |
20-day SMA: | 174.26 | Sell |
50-day SMA: | 168.9 | Buy |
200-day SMA: | 147.6 | Buy |
8-day EMA: | 174.05 | Sell |
20-day EMA: | 173.56 | Sell |
50-day EMA: | 169.53 | Buy |
200-day EMA: | 152.7 | Buy |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.13 per share, and an increase next year of $0.30 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $6.22 per share.
Intellia Therapeutics Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |